Central venous lesion represents one of the common complications affecting vascular access in hemodialysis patients, potentially compromising hemodialysis efficacy. The management of symptomatic central venous lesion remains a critical challenge in clinical practice. Current primary treatment strategies include percutaneous transluminal angioplasty and percutaneous transluminal stenting. Advances in techniques such as sharp recanalization and the mother-child platform approach, along with the development of high-pressure balloons, paclitaxel- coated balloons, and covered stents, have significantly improved procedural success rates. However, unresolved issues persist, including standardized treatment protocols, technical considerations for lesion traversal, and optimal stent selection criteria. This article comprehensively reviews the treatment principles, lesion passage techniques, treatment techniques, and recent advancements of central venous lesion.

Central venous lesion represents one of the common complications affecting vascular access in hemodialysis patients, potentially compromising hemodialysis efficacy. The management of symptomatic central venous lesion remains a critical challenge in clinical practice. Current primary treatment strategies include percutaneous transluminal angioplasty and percutaneous transluminal stenting. Advances in techniques such as sharp recanalization and the mother-child platform approach, along with the development of high-pressure balloons, paclitaxel- coated balloons, and covered stents, have significantly improved procedural success rates. However, unresolved issues persist, including standardized treatment protocols, technical considerations for lesion traversal, and optimal stent selection criteria. This article comprehensively reviews the treatment principles, lesion passage techniques, treatment techniques, and recent advancements of central venous lesion.

Objective To investigate the incidence of moderate to severe cancer-related fatigue in bone tumor chemotherapy patients and its influence factors were analyzed.Methods Totally 265 bone tumor chemotherapy patients who received chemotherapy for the first time in our hospital from January 2021 to June 2023 were selected as the research subjects by convenience sampling method.A general information survey Hamilton anxiety scale,Hamilton depression scale,simplified coping style questionnaire and the Piper fatigue scale revised(PFS-R)were used to investigate the cancer-related fatigue status of bone tumor chemotherapy patients,and the logistic regression analysis was used to analyze its influencing factors.Results Totally 239 patients completed the study.Among 239 bone tumor chemotherapy patients,154 cases had moderate to severe cancer-related fatigue,the incidence rate was 64.44%.The Logistic regression analysis showed that daily sleep time<5 hours,low body weight,and high anxiety and depression scores were risk factors for moderate to severe cancer-related fatigue in bone tumor chemotherapy patients,while active coping strategies was protective factors(all P<0.05).Conclusion The incidence of moderate to severe cancer-related fatigue in bone tumor chemotherapy patients is relatively high.Preintervention is needed for patients with low body weight,short sleep time,anxiety,depression,and negative coping strategies to reduce the occurrence of moderate to severe cancer-related fatigue in patients.

Objective To investigate the incidence of moderate to severe cancer-related fatigue in bone tumor chemotherapy patients and its influence factors were analyzed.Methods Totally 265 bone tumor chemotherapy patients who received chemotherapy for the first time in our hospital from January 2021 to June 2023 were selected as the research subjects by convenience sampling method.A general information survey Hamilton anxiety scale,Hamilton depression scale,simplified coping style questionnaire and the Piper fatigue scale revised(PFS-R)were used to investigate the cancer-related fatigue status of bone tumor chemotherapy patients,and the logistic regression analysis was used to analyze its influencing factors.Results Totally 239 patients completed the study.Among 239 bone tumor chemotherapy patients,154 cases had moderate to severe cancer-related fatigue,the incidence rate was 64.44%.The Logistic regression analysis showed that daily sleep time<5 hours,low body weight,and high anxiety and depression scores were risk factors for moderate to severe cancer-related fatigue in bone tumor chemotherapy patients,while active coping strategies was protective factors(all P<0.05).Conclusion The incidence of moderate to severe cancer-related fatigue in bone tumor chemotherapy patients is relatively high.Preintervention is needed for patients with low body weight,short sleep time,anxiety,depression,and negative coping strategies to reduce the occurrence of moderate to severe cancer-related fatigue in patients.

Hip fracture is considered as the most severe osteoporotic fracture characterized by high disability and mortality in the elderly. Improved surgical techniques and multidisciplinary team play an active role in alleviating prognosis, which places higher demands on perioperative nursing. Dysfunction, complications, and secondary impact of anaesthesia and surgery add more difficulties to clinical nursing. Besides, there still lack clinical practices in perioperative nursing for elderly patients with hip fracture in China. In this context, led by the Orthopedic Nursing Committee of Chinese Nursing Association, the Expert consensus on clinical practice in perioperative nursing for elderly patients with hip fracture ( version 2023) is developed based on the evidence-based medicine. This consensus provides 11 recommendations on elderly patients with hip fracture from aspects of perioperative health education, condition monitoring and inspection, complication risk assessment and prevention, and rehabilitation, in order to provide guiding advices for clinical practice, improve the quality of nursing and ameliorate the prognosis of elderly patients with hip fracture.